Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4215269
Max Phase: Preclinical
Molecular Formula: C38H32N2O7S
Molecular Weight: 660.75
Molecule Type: Small molecule
Associated Items:
ID: ALA4215269
Max Phase: Preclinical
Molecular Formula: C38H32N2O7S
Molecular Weight: 660.75
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H]1[C@@H](C(=O)OC)C(c2ccccc2)(c2ccccc2)N(c2nc(-c3ccccc3)c(C(=O)c3ccccc3)s2)[C@H]1C(=O)OC
Standard InChI: InChI=1S/C38H32N2O7S/c1-45-34(42)28-29(35(43)46-2)38(26-20-12-6-13-21-26,27-22-14-7-15-23-27)40(31(28)36(44)47-3)37-39-30(24-16-8-4-9-17-24)33(48-37)32(41)25-18-10-5-11-19-25/h4-23,28-29,31H,1-3H3/t28-,29-,31+/m0/s1
Standard InChI Key: AJKARVQECXEYPO-GSBZAIBZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 660.75 | Molecular Weight (Monoisotopic): 660.1930 | AlogP: 5.92 | #Rotatable Bonds: 9 |
Polar Surface Area: 112.10 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.63 | CX LogD: 7.63 |
Aromatic Rings: 5 | Heavy Atoms: 48 | QED Weighted: 0.11 | Np Likeness Score: -0.33 |
1. Nural Y, Gemili M, Ulger M, Sari H, De Coen LM, Sahin E.. (2018) Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives., 28 (5): [PMID:29433925] [10.1016/j.bmcl.2018.01.045] |
Source(1):